Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Epilepsy (BASKET).php on line 2
Epilepsy (BASKET)
LE WE PMID CA
Epilepsy (BASKET)15Epilepsie (allg)

Action potential

Adenosine

ALDH7A1 alpha aminoadipic semialdehyde dehydrogenase

Amygdala

Anesthesia (Methods)

Angelman s syndrome

Anoxic epileptic seizures

Autism

Autosomal dominant epilepsy with febrile seizures plus

Autosomal dominant Juvenile Myoclonic Epilepsy

Benign familial neonatal seizures

Brain injury

CACNA1A principal subunit of the P Q calcium channel

Childhood absence epilepsy

CLCN2 ClC2

CNS (Cerebral cortex)

CNS (Cortical dysplasia)

CNS (Deep brain stimulation)

CNS (Electrode)

CNS (Electroencephalography)

CNS (Eloquence)

CNS (Imaging)

CNS (Magnetic stimulation)

CNS (Magnetoencephalography)

CNS (Neoplasia)

CNS (PET)

CNS (Stroke BASKET)

Convection enhanced delivery

Dravet s syndrome

Drug delivery

Epilepsy (BASKET)

Epilepsy (Catamenial)

Epilepsy (Generalized epilepsy with febrile seizures plus)

Epilepsy (Landau Kleffner s syndrome)

Episodic ataxia type 2

Febrile convulsions

Frontal cortex

GABRA1

GABRA4

GABRA5

GABRA6

GABRB3

GABRD

GABRE

GABRG2

GABRG3

GABRP

Heart (Coronary heart disease Main stenosis)

Hippocampus

History of medicine

Immunopsychiatry

Infantile spasms

Ion channel (Calcium)

Ion channel (Chloride)

Ion channel (Sodium)

Juvenile myoclonic epilepsy

KCC3

KCNQ2

Ketogenic diet

Levetiracetam

Masturbation

Melatonin

Menstruation

MTOR

Multiple sclerosis

Myocloni

NaV1 1

Neonatology

Neuromytonia

Neurosteroids

Oxcarbazepine

Panayiotopoulos syndrome

Piperideine 6 carboxylic acid

Psychosurgery

Pyridoxal phosphate

Receptor (GABA A)

Receptor (GABA)

Regeneration of tissues and other biologic structures

Retigabine

Rufinamide

SCN1A

SCN2A

SCN3A

SCN8A

SCN9A

Somatostatin

Spikes and waves

Stem cell (Adult somatic derived reprogrammed)

Stem cell (Adult)

Stem cell (Embryonal)

Sturge Weber s syndrome

Syncope

Tiagabine

Topiramate

Transporter (Chloride and potassium)

Tuberous sclerosis

UBE3A

Vigabatrine

Vitamin B6

West s syndrome

Zonisamide

2006  
1
The first seizure and its management in adults and children.
[16470055] BMJ 332(7537): 339-42 (2006)
2005  
2
Status epilepticus: an evidence based guide.
[16179702] BMJ 331(7518): 673-7 (2005)
2008  
3
1997  
4
Pharmacologic and dietary therapies in epilepsy: conventional treatments and recent advances.
[9160061] South Med J 90(5): 471-80 (1997)
1989  
5
Surgical management of epilepsy.
[2660291] South Med J 82(6): 736-42 (1989)
1986  
6
Pseudoseizures: an overview.
[3518074] South Med J 79(5): 600-7 (1986)
2002  
7
A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus.
[11937649] QJM 95(4): 225-31 (2002)
1998  
8
Features and management of poisoning with modern drugs used to treat epilepsy.
[9709465] QJM 91(5): 325-32 (1998)
2001  
9
Recent advances in the diagnosis and management of epilepsy.
[11406679] Hong Kong Med J 7(1): 73-84 (2001)
2002  
10
Molecular biology and genetics of epilepsy.
[12002619] Acta Med Okayama 56(2): 57-68 (2002)
1996  
11
New antiepileptic drugs. II. Clinical use.
[8878797] J Korean Med Sci 11(4): 289-304 (1996)
1996  
12
New antiepileptic drugs--I. Basic characteristics.
[8835756] J Korean Med Sci 11(2): 99-110 (1996)
1992  
13
2000  
14
The neurosurgical treatment of epilepsy.
[11115221] Arch Fam Med 9(10): 1142-7 (2000)
2008  
15
Sudden unexpected death in epilepsy: impact, mechanisms, and prevention.
[18540150] Cleve Clin J Med 75 Suppl 2(-): S66-70 (2008)
1998  
16
Electroencephalography and video-electroencephalography in the classification of childhood epilepsy syndromes.
[9764078] J R Soc Med 91(5): 251-9 (1998)
1991  
17
1991  
18
Neuropsychological investigation of temporal lobe epilepsy.
[1886113] J R Soc Med 84(8): 460-5 (1991)
1991  
19
1991  
20
Modern treatment strategies for patients with epilepsy: a review.
[2013897] J R Soc Med 84(3): 159-62 (1991)
2000  
21
Status epilepticus. Current concepts and management.
[11013800] Can Fam Physician 46(-): 1817-23 (2000)
2005  
22
2009  
23
Deep brain stimulation: a new approach to the treatment of epilepsy.
[19623308] Dtsch Arztebl Int 106(24): 407-12 (2009)
2009  
24
2008  
25
2008  
26
Role of brain inflammation in epileptogenesis.
[18306464] Yonsei Med J 49(1): 1-18 (2008)
2008  
27
The howling cortex: seizures and general anesthetic drugs.
[18931234] Anesth Analg 107(5): 1689-703 (2008)
2002  
28
Clinical review: status epilepticus.
[11983039] Crit Care 6(2): 137-42 (2002)
2001  
29
Emergency department management of patients with seizures: a multicenter study.
[11388937] Acad Emerg Med 8(6): 622-8 (2001)
2005  
30
Early management of adults with an uncomplicated first generalised seizure.
[15788819] Emerg Med J 22(4): 237-42 (2005)
2002  
31
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Propofol for resistant status epilepticus.
[11904266] Emerg Med J 19(2): 143-4 (2002)
2002  
32
Emergency department drug therapy for status epilepticus in adults.
[11904250] Emerg Med J 19(2): 96-100 (2002)
1999  
33
Management of status epilepticus.
[16599876] Crit Care Resusc 1(4): 344-53 (1999)
2010  
34
Nonconvulsive status epilepticus and coma.
[19744116] Epilepsia 51(2): 177-90 (2010)
2010  
35
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.
[19744114] Epilepsia 51(1): 7-26 (2010)
2009  
36
Novel anesthetics and other treatment strategies for refractory status epilepticus.
[19941525] Epilepsia 50 Suppl 12(-): 51-3 (2009)
2009  
37
What is the promise of new antiepileptic drugs in status epilepticus? Focus on brivaracetam, carisbamate, lacosamide, NS-1209, and topiramate.
[19941524] Epilepsia 50 Suppl 12(-): 49-50 (2009)
2009  
38
Pharmacodynamic and pharmacokinetic characteristics of intravenous drugs in status epilepticus.
[19941523] Epilepsia 50 Suppl 12(-): 44-8 (2009)
2009  
39
What is the relative value of the standard anticonvulsants: Phenytoin and fosphenytoin, phenobarbital, valproate, and levetiracetam?
[19941522] Epilepsia 50 Suppl 12(-): 40-3 (2009)
2009  
40
Physiology of epilepsia partialis continua and subcortical mechanisms of status epilepticus.
[19941509] Epilepsia 50 Suppl 12(-): 7-9 (2009)
2009  
41
Basic physiology of limbic status epilepticus.
[19941508] Epilepsia 50 Suppl 12(-): 5-6 (2009)
2009  
42
Reevaluating the mechanisms of focal ictogenesis: The role of low-voltage fast activity.
[19674056] Epilepsia 50(12): 2514-25 (2009)
2009  
43
Surgical treatment of the extratemporal epilepsies.
[19702737] Epilepsia 50 Suppl 8(-): 69-74 (2009)
2009  
44
2009  
45
Refractory seizures: try additional antiepileptic drugs (after two have failed) or go directly to early surgery evaluation?
[19702735] Epilepsia 50 Suppl 8(-): 57-62 (2009)
2009  
46
Treatment algorithms in refractory partial epilepsy.
[19702734] Epilepsia 50 Suppl 8(-): 51-6 (2009)
2009  
47
Guidelines for imaging infants and children with recent-onset epilepsy.
[19389145] Epilepsia 50(9): 2147-53 (2009)
2009  
48
Long-term seizure outcome of surgery versus no surgery for drug-resistant partial epilepsy: a review of controlled studies.
[19243421] Epilepsia 50(6): 1301-9 (2009)
2009  
49
Familial mesial temporal lobe epilepsies: clinical and genetic features.
[19469849] Epilepsia 50 Suppl 5(-): 55-7 (2009)
2009  
50
Lateral temporal lobe epilepsies: clinical and genetic features.
[19469848] Epilepsia 50 Suppl 5(-): 52-4 (2009)
2009  
51
Malignant migrating partial seizures in infancy: an epilepsy syndrome of unknown etiology.
[19469847] Epilepsia 50 Suppl 5(-): 49-51 (2009)
2009  
52
Myoclonic status in nonprogressive encephalopathies: an update.
[19469845] Epilepsia 50 Suppl 5(-): 41-4 (2009)
2009  
53
Familial benign nonprogressive myoclonic epilepsies.
[19469844] Epilepsia 50 Suppl 5(-): 37-40 (2009)
2009  
54
The autosomal recessively inherited progressive myoclonus epilepsies and their genes.
[19469843] Epilepsia 50 Suppl 5(-): 29-36 (2009)
2009  
55
Idiopathic generalized epilepsy (IGE) syndromes in development: IGE with absences of early childhood, IGE with phantom absences, and perioral myoclonia with absences.
[19469842] Epilepsia 50 Suppl 5(-): 24-8 (2009)
2009  
56
The impact of genetics on the classification of epilepsy syndromes.
[19469839] Epilepsia 50 Suppl 5(-): 11-4 (2009)
2009  
57
The concept of the epilepsy syndrome: how useful is it in clinical practice?
[19469838] Epilepsia 50 Suppl 5(-): 4-10 (2009)
2009  
58
Efficacy, safety, and tolerability of the low glycemic index treatment in pediatric epilepsy.
[19220406] Epilepsia 50(5): 1118-26 (2009)
2009  
59
Epilepsy surgery: historical highlights 1909-2009.
[19298436] Epilepsia 50 Suppl 3(-): 131-51 (2009)
2009  
60
Neurochemistry and epileptology.
[19298429] Epilepsia 50 Suppl 3(-): 17-29 (2009)
2009  
61
Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
[19054403] Epilepsia 50(3): 475-9 (2009)
2009  
62
Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
[18627416] Epilepsia 50(3): 387-97 (2009)
2009  
63
Posttraumatic epilepsy: the challenge of translating discoveries in the laboratory to pathways to a cure.
[19187293] Epilepsia 50 Suppl 2(): 41-5 (2009)
2009  
64
From traumatic brain injury to posttraumatic epilepsy: what animal models tell us about the process and treatment options.
[19187291] Epilepsia 50 Suppl 2(-): 21-9 (2009)
2009  
65
Posttraumatic epilepsy: the endophenotypes of a human model of epileptogenesis.
[19187290] Epilepsia 50 Suppl 2(): 14-20 (2009)
2009  
66
Preventing and treating posttraumatic seizures: the human experience.
[19187289] Epilepsia 50 Suppl 2(): 10-3 (2009)
2009  
67
Epilepsy after head injury: an overview.
[19187288] Epilepsia 50 Suppl 2(): 4-9 (2009)
2008  
68
When drugs and surgery don't work.
[19087121] Epilepsia 49 Suppl 9(-): 79-84 (2008)
2008  
69
The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus.
[19087120] Epilepsia 49 Suppl 9(-): 74-8 (2008)
2008  
70
Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs.
[19087119] Epilepsia 49 Suppl 9(-): 63-73 (2008)
2008  
71
Typical absence seizures and related epileptic syndromes: assessment of current state and directions for future research.
[19049569] Epilepsia 49(12): 2131-9 (2008)
2008  
72
Characteristics and clinical significance of subclinical seizures.
[18503561] Epilepsia 49(12): 2016-21 (2008)
2008  
73
Attention impairment in rolandic epilepsy: systematic review.
[18410358] Epilepsia 49(9): 1570-80 (2008)
2008  
74
Temporal lobe epilepsy surgery and the quest for optimal extent of resection: a review.
[18410360] Epilepsia 49(8): 1296-307 (2008)
2008  
75
The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus.
[18638280] Epilepsia 49(7): 1277-85 (2008)
2008  
76
Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
[18397299] Epilepsia 49(7): 1239-76 (2008)
2007  
77
Evidence-based epileptology, randomized controlled trials, and SANAD: a critical clinical view.
[17565590] Epilepsia 48(7): 1268-74 (2007)
2007  
78
Choosing a first drug treatment for epilepsy after SANAD: randomized controlled trials, systematic reviews, guidelines and treating patients.
[17442006] Epilepsia 48(7): 1259-63 (2007)
2007  
79
Autonomic status epilepticus in Panayiotopoulos syndrome and other childhood and adult epilepsies: a consensus view.
[17442005] Epilepsia 48(6): 1165-72 (2007)
2007  
80
Status epilepticus treatment guidelines.
[18330014] Epilepsia 48 Suppl 8(-): 99-102 (2007)
2007  
81
Out-of-hospital treatment of status epilepticus and prolonged seizures.
[18330013] Epilepsia 48 Suppl 8(-): 96-8 (2007)
2007  
82
The epidemiology of convulsive and nonconvulsive status epilepticus.
[18330009] Epilepsia 48 Suppl 8(-): 82-4 (2007)
2007  
83
The surgical treatment of status epilepticus.
[18330003] Epilepsia 48 Suppl 8(-): 61-5 (2007)
2007  
84
Intensive care unit management of patients with status epilepticus.
[18330002] Epilepsia 48 Suppl 8(-): 59-60 (2007)
2007  
85
The use of valproate and new antiepileptic drugs in status epilepticus.
[18329999] Epilepsia 48 Suppl 8(-): 49-51 (2007)
2007  
86
How urgent is the treatment of nonconvulsive status epilepticus?
[18329997] Epilepsia 48 Suppl 8(-): 44-5 (2007)
2007  
87
EEG criteria for nonconvulsive status epilepticus.
[18329995] Epilepsia 48 Suppl 8(-): 39-41 (2007)
2007  
88
2007  
89
Alterations of phosphatidylinositol 3-kinase pathway components in epilepsy-associated glioneuronal lesions.
[17910583] Epilepsia 48 Suppl 5(-): 65-73 (2007)
2007  
90
Neuroprotective strategies to avert seizure-induced neurodegeneration in epilepsy.
[17571357] Epilepsia 48 Suppl 2(-): 107-17 (2007)
2007  
91
Hemispheric surgery in children with refractory epilepsy: seizure outcome, complications, and adaptive function.
[17241220] Epilepsia 48(1): 133-40 (2007)
2006  
92
The blood-brain barrier and epilepsy.
[17116015] Epilepsia 47(11): 1761-74 (2006)
2006  
93
Proposed diagnostic scheme for the classification of epileptic seizures and epilepsies (ILAE, 2001): proposal from Japan Epilepsy Society.
[16981882] Epilepsia 47(9): 1588-9; discussion 1590-1 (2006)
2006  
94
Nonconvulsive seizures in the pediatric intensive care unit: etiology, EEG, and brain imaging findings.
[16981868] Epilepsia 47(9): 1510-8 (2006)
2006  
95
Nonconvulsive status epilepticus in children: clinical and EEG characteristics.
[16981867] Epilepsia 47(9): 1504-9 (2006)
2006  
96
Idiopathic generalized epilepsies of adolescence.
[17105478] Epilepsia 47 Suppl 2(-): 107-10 (2006)
2006  
97
Nocturnal frontal lobe epilepsy.
[17105470] Epilepsia 47 Suppl 2(-): 83-6 (2006)
2006  
98
Autistic spectrum disorder: evaluating a possible contributing or causal role of epilepsy.
[17105469] Epilepsia 47 Suppl 2(-): 79-82 (2006)
2006  
99
Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome.
[17105467] Epilepsia 47 Suppl 2(-): 71-5 (2006)
2006  
100
The spectrum of idiopathic Rolandic epilepsy syndromes and idiopathic occipital epilepsies: from the benign to the disabling.
[17105465] Epilepsia 47 Suppl 2(-): 62-6 (2006)
2006  
101
The management of refractory status epilepticus: an update.
[17044824] Epilepsia 47 Suppl 1(-): 35-40 (2006)
2006  
102
Interictal EEG and the diagnosis of epilepsy.
[17044820] Epilepsia 47 Suppl 1(-): 14-22 (2006)
2005  
103
Brain inflammation in epilepsy: experimental and clinical evidence.
[16302852] Epilepsia 46(11): 1724-43 (2005)
2005  
104
Photic- and pattern-induced seizures: a review for the Epilepsy Foundation of America Working Group.
[16146439] Epilepsia 46(9): 1426-41 (2005)
2005  
105
Photic- and pattern-induced seizures: expert consensus of the Epilepsy Foundation of America Working Group.
[16146438] Epilepsia 46(9): 1423-5 (2005)
2005  
106
Mortality of epilepsy in developed countries: a review.
[16393174] Epilepsia 46 Suppl 11(-): 18-27 (2005)
2005  
107
Genetic focal epilepsies: state of the art and paths to the future.
[16359475] Epilepsia 46 Suppl 10(-): 61-7 (2005)
2005  
108
Neonatal epilepsy syndromes and GEFS+: mechanistic considerations.
[16359473] Epilepsia 46 Suppl 10(-): 51-8 (2005)
2005  
109
Neonatal epilepsy syndromes and generalized epilepsy with febrile seizures plus (GEFS+).
[16359471] Epilepsia 46 Suppl 10(-): 41-7 (2005)
2005  
110
Neurocutaneous syndromes and epilepsy-issues in diagnosis and management.
[16359466] Epilepsia 46 Suppl 10(-): 17-23 (2005)
2005  
111
Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs.
[16302891] Epilepsia 46 Suppl 9(-): 161-8 (2005)
2005  
112
Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs.
[16302889] Epilepsia 46 Suppl 9(-): 149-53 (2005)
2005  
113
Properties of antiepileptic drugs in the treatment of idiopathic generalized epilepsies.
[16302888] Epilepsia 46 Suppl 9(-): 140-8 (2005)
2005  
114
Seizure aggravation in idiopathic generalized epilepsies.
[16302887] Epilepsia 46 Suppl 9(-): 133-9 (2005)
2005  
115
Practical management issues for idiopathic generalized epilepsies.
[16302886] Epilepsia 46 Suppl 9(-): 125-32 (2005)
2005  
116
Best practice guidelines for the management of women with epilepsy.
[16302885] Epilepsia 46 Suppl 9(-): 117-24 (2005)
2005  
117
Management guidelines for children with idiopathic generalized epilepsy.
[16302884] Epilepsia 46 Suppl 9(-): 112-6 (2005)
2005  
118
Brain imaging in idiopathic generalized epilepsies.
[16302883] Epilepsia 46 Suppl 9(-): 108-11 (2005)
2005  
119
Status epilepticus in idiopathic generalized epilepsy.
[16302878] Epilepsia 46 Suppl 9(-): 73-9 (2005)
2005  
120
Photosensitivity in idiopathic generalized epilepsies.
[16302877] Epilepsia 46 Suppl 9(-): 67-72 (2005)
2005  
121
Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy.
[16302876] Epilepsia 46 Suppl 9(-): 57-66 (2005)
2005  
122
Seizures of idiopathic generalized epilepsies.
[16302874] Epilepsia 46 Suppl 9(-): 34-47 (2005)
2005  
123
Cellular and network mechanisms of spike-wave seizures.
[16302873] Epilepsia 46 Suppl 9(-): 21-33 (2005)
2005  
124
Genetics of idiopathic generalized epilepsies.
[16302872] Epilepsia 46 Suppl 9(-): 15-20 (2005)
2005  
125
Epidemiology of idiopathic generalized epilepsies.
[16302871] Epilepsia 46 Suppl 9(-): 10-4 (2005)
2005  
126
Idiopathic generalized epilepsies: a review and modern approach.
[16302869] Epilepsia 46 Suppl 9(-): 1-6 (2005)
2005  
127
An introduction to antiepileptic drugs.
[15968807] Epilepsia 46 Suppl 4(-): 31-7 (2005)
2005  
128
Genetics of idiopathic epilepsies.
[15816978] Epilepsia 46 Suppl 1(-): 38-43 (2005)
2005  
129
Genetic malformations of the cerebral cortex and epilepsy.
[15816977] Epilepsia 46 Suppl 1(-): 32-7 (2005)
2005  
130
Callosal bisection and transcallosal secondary antiepileptogenesis.
[15816970] Epilepsia 46 Suppl 1(-): 2-6 (2005)
2004  
131
Prescience as an aura of temporal lobe epilepsy.
[15270767] Epilepsia 45(8): 982-4 (2004)
2004  
132
Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections.
[15101835] Epilepsia 45(5): 534-43 (2004)
2004  
133
Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
[15101822] Epilepsia 45(5): 410-23 (2004)
2004  
134
Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.
[15101821] Epilepsia 45(5): 401-9 (2004)
2004  
135
The use of antiepileptic drugs--principles and practice.
[15315513] Epilepsia 45 Suppl 6(-): 28-34 (2004)
2004  
136
Following catastrophic epilepsy patients from childhood to adulthood.
[15283708] Epilepsia 45 Suppl 5(-): 23-6 (2004)
2004  
137
Nonpharmacologic treatment of the catastrophic epilepsies of childhood.
[15283707] Epilepsia 45 Suppl 5(-): 17-22 (2004)
2004  
138
Pharmacologic treatment of the catastrophic epilepsies.
[15283706] Epilepsia 45 Suppl 5(-): 12-6 (2004)
2004  
139
Basic science behind the catastrophic epilepsies.
[15283705] Epilepsia 45 Suppl 5(-): 5-11 (2004)
2004  
140
Status epilepticus and periictal imaging.
[15281962] Epilepsia 45 Suppl 4(-): 72-7 (2004)
2004  
141
Magnetoencephalography in epilepsy.
[15281961] Epilepsia 45 Suppl 4(-): 61-71 (2004)
2004  
142
The treatment of nonepileptic seizures: historical perspectives and future directions.
[15186340] Epilepsia 45 Suppl 2(-): 15-21 (2004)
2003  
143
Brain tumor and seizures: pathophysiology and its implications for treatment revisited.
[12919395] Epilepsia 44(9): 1223-32 (2003)
2003  
144
Practice parameter: temporal lobe and localized neocortical resections for epilepsy.
[12790886] Epilepsia 44(6): 741-51 (2003)
2003  
145
Clinical presentations and phenomenology of myoclonus.
[14641566] Epilepsia 44 Suppl 11(-): 7-12 (2003)
2003  
146
Classification of the myoclonic epilepsies.
[14641565] Epilepsia 44 Suppl 11(-): 2-6 (2003)
2003  
147
Noninvasive methods for evaluating the localization and propagation of epileptic activity.
[14641558] Epilepsia 44 Suppl 12(-): 21-9 (2003)
2003  
148
Treatment strategies for myoclonic seizures and epilepsy syndromes with myoclonic seizures.
[14641568] Epilepsia 44 Suppl 11(-): 27-37 (2003)
2003  
149
Recent developments in the quest for myoclonic epilepsy genes.
[14641567] Epilepsia 44 Suppl 11(-): 13-26 (2003)
2003  
150
Overview of studies to prevent posttraumatic epilepsy.
[14511391] Epilepsia 44 Suppl 10(-): 21-6 (2003)
2003  
151
Epidemiology of posttraumatic epilepsy: a critical review.
[14511389] Epilepsia 44 Suppl 10(-): 11-7 (2003)
2003  
152
Clinical trials for treatment of primary generalized epilepsies.
[12919339] Epilepsia 44 Suppl 7(-): 44-50 (2003)
2003  
153
Randomized controlled trials of epilepsy surgery.
[12919338] Epilepsia 44 Suppl 7(-): 38-43 (2003)
2003  
154
Evaluating devices for treating epilepsy.
[12919337] Epilepsia 44 Suppl 7(-): 30-7 (2003)
2003  
155
Beyond pharmacotherapy: surgical management.
[12859359] Epilepsia 44 Suppl 5(-): 23-8 (2003)
2003  
156
From molecules to networks: cortical/subcortical interactions in the pathophysiology of idiopathic generalized epilepsy.
[12752456] Epilepsia 44 Suppl 2(-): 7-15 (2003)
2003  
157
Overview: idiopathic generalized epilepsies.
[12752455] Epilepsia 44 Suppl 2(-): 2-6 (2003)
2003  
158
Current status of surgery in the management of epilepsy.
[12558832] Epilepsia 44 Suppl 1(-): 43-7 (2003)
2003  
159
The natural history of epilepsy in the era of new antiepileptic drugs and surgical treatment.
[12558826] Epilepsia 44 Suppl 1(-): 17-20 (2003)
2002  
160
Long-term psychosocial outcomes of anterior temporal lobectomy.
[12181009] Epilepsia 43(8): 896-903 (2002)
2002  
161
Frequency and significance of acute postoperative seizures following epilepsy surgery in children and adolescents.
[12181006] Epilepsia 43(8): 874-81 (2002)
2002  
162
Frontal lobe tumoral epilepsy: clinical, neurophysiologic features and predictors of surgical outcome.
[12102675] Epilepsia 43(7): 727-33 (2002)
2002  
163
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis.
[12027911] Epilepsia 43(5): 505-13 (2002)
2002  
164
Memory deficits after resection from left or right anterior temporal lobe in humans: a meta-analytic review.
[11906514] Epilepsia 43(3): 283-91 (2002)
2002  
165
Focal ictal beta discharge on scalp EEG predicts excellent outcome of frontal lobe epilepsy surgery.
[11906513] Epilepsia 43(3): 277-82 (2002)
2002  
166
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review.
[11903460] Epilepsia 43(2): 146-53 (2002)
2002  
167
Functional and morphological changes in the hippocampal neuronal circuits associated with epileptic seizures.
[12383280] Epilepsia 43 Suppl 9(-): 44-9 (2002)
2002  
168
2002  
169
Adolescent seizures and epilepsy syndromes.
[12060005] Epilepsia 43 Suppl 3(-): 33-52 (2002)
2002  
170
Epileptic syndromes in childhood: clinical features, outcomes, and treatment.
[12060004] Epilepsia 43 Suppl 3(-): 27-32 (2002)
2002  
171
EEG in benign and malignant epileptic syndromes of childhood.
[12060003] Epilepsia 43 Suppl 3(-): 17-26 (2002)
2002  
172
Infantile seizures and epilepsy syndromes.
[12060002] Epilepsia 43 Suppl 3(-): 11-6 (2002)
2002  
173
Neonatal seizures and syndromes.
[12060001] Epilepsia 43 Suppl 3(-): 2-10 (2002)
2001  
174
Seizure outcome after temporal lobectomy: current research practice and findings.
[11737164] Epilepsia 42(10): 1288-307 (2001)
2001  
175
Generalized epileptic disorders: an update.
[11440339] Epilepsia 42(4): 445-57 (2001)
2001  
176
Propofol and midazolam in the treatment of refractory status epilepticus.
[11442156] Epilepsia 42(3): 380-6 (2001)
2001  
177
Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons.
[11442155] Epilepsia 42(3): 372-9 (2001)
2001  
178
Idiopathic generalized epilepsy with generalized and other seizures in adolescence.
[11442147] Epilepsia 42(3): 317-20 (2001)
2001  
179
Classification of epileptic disorders.
[11442146] Epilepsia 42(3): 316 (2001)
2001  
180
Multiple subpial transections: the Yale experience.
[11240594] Epilepsia 42(2): 226-9 (2001)
2001  
181
The management of refractory idiopathic epilepsies.
[11520320] Epilepsia 42 Suppl 3(-): 31-5 (2001)
2001  
182
2000  
183
Intractable seizures of frontal lobe origin: clinical characteristics, localizing signs, and results of surgery.
[10999553] Epilepsia 41(9): 1139-52 (2000)
2000  
184
The electroencephalographic features of benign centrotemporal (rolandic) epilepsy of childhood.
[10961638] Epilepsia 41(8): 1053-6 (2000)
2000  
185
Clinical spectrum of benign focal epilepsies of childhood.
[10961637] Epilepsia 41(8): 1051-2 (2000)
2000  
186
Benign focal epilepsies of childhood: genetically determined pathophysiology. Report of an international workshop.
[10961636] Epilepsia 41(8): 1049-50 (2000)
2000  
187
Indication for anterior temporal lobectomy in patients with temporal lobe epilepsy and psychopathology.
[11156510] Epilepsia 41 Suppl 9(-): 39-42 (2000)
2000  
188
Surgical indication for refractory childhood epilepsy.
[11156505] Epilepsia 41 Suppl 9(-): 21-5 (2000)
2000  
189
New insights into the clinical management of partial epilepsies.
[11045435] Epilepsia 41 Suppl 5(-): S13-17 (2000)
2000  
190
Temporal lobe epilepsy: when are invasive recordings needed?
[11001338] Epilepsia 41 Suppl 3(-): S61-74 (2000)
2000  
191
Integration of EEG, MRI, and SPECT in localizing the seizure focus for epilepsy surgery.
[11001336] Epilepsia 41 Suppl 3(-): S48-54 (2000)
2000  
192
Postlesional epilepsy: the ultimate brain plasticity.
[10999537] Epilepsia 41 Suppl 6(-): S153-61 (2000)
2000  
193
Adverse effects of antiepileptic drugs.
[10885739] Epilepsia 41 Suppl 2(-): S42-52 (2000)
2000  
194
Status epilepticus: risk factors and complications.
[10885737] Epilepsia 41 Suppl 2(-): S23-30 (2000)
2000  
195
Is epilepsy a progressive disease? The neurobiological consequences of epilepsy.
[10885736] Epilepsia 41 Suppl 2(-): S13-22 (2000)
2000  
196
Catastrophic epilepsy in childhood.
[10885734] Epilepsia 41 Suppl 2(-): S2-6 (2000)
1999  
197
The pharmacologic basis of antiepileptic drug action.
[10565572] Epilepsia 40(11): 1471-83 (1999)
1999  
198
Recent advances in the genetics of epilepsy: insights from human and animal studies.
[10528928] Epilepsia 40(10): 1329-52 (1999)
1999  
199
Focal status epilepticus: clinical features and significance of different EEG patterns.
[10487189] Epilepsia 40(9): 1254-60 (1999)
1999  
200
New antiepileptic drugs: comparison of key clinical trials.
[10386528] Epilepsia 40(5): 590-600 (1999)
1999  
201
Newly diagnosed epilepsy in children: presentation at diagnosis.
[10219270] Epilepsia 40(4): 445-52 (1999)
1999  
202
Depression in epilepsy: etiology, phenomenology, and treatment.
[10609603] Epilepsia 40 Suppl 10(-): S21-47 (1999)
1999  
203
Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications.
[10609602] Epilepsia 40 Suppl 10(-): S2-20 (1999)
1999  
204
Cost and cost-effectiveness of epilepsy surgery.
[10563593] Epilepsia 40 Suppl 8(-): 32-9 (1999)
1999  
205
Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.
[10530688] Epilepsia 40 Suppl 5(-): S2-10 (1999)
1999  
206
Use of new antiepileptic drugs in the treatment of childhood epilepsy.
[10530681] Epilepsia 40 Suppl 6(-): S29-38; discussion S73-4 (1999)
1999  
207
Idiopathic epilepsies with a complex mode of inheritance.
[10446745] Epilepsia 40 Suppl 3(-): 12-6 (1999)
1999  
208
Idiopathic epilepsies with a monogenic mode of inheritance.
[10446744] Epilepsia 40 Suppl 3(-): 9-11 (1999)
1999  
209
Status epilepticus-induced neuronal injury and network reorganization.
[10421559] Epilepsia 40 Suppl 1(-): S34-9; discussion S40-1 (1999)
1999  
210
Chronic epileptogenic cellular alterations in the limbic system after status epilepticus.
[10421558] Epilepsia 40 Suppl 1(-): S23-33; discussion S40-1 (1999)
1999  
211
Acute cellular alterations in the hippocampus after status epilepticus.
[10421557] Epilepsia 40 Suppl 1(-): S9-20; discussion S21-2 (1999)
1999  
212
Status epilepticus: an overview of the clinical problem.
[10421556] Epilepsia 40 Suppl 1(-): S3-8; discussion S21-2 (1999)
1998  
213
Multiple subpial transection in patients with extratemporal epilepsy.
[9637596] Epilepsia 39 Suppl 4(-): S81-9 (1998)
1998  
214
Motor and sensory mapping of the frontal and occipital lobes.
[9637595] Epilepsia 39 Suppl 4(-): S69-80 (1998)
1998  
215
1998  
216
1998  
217
Surgical treatment for perirolandic lesional epilepsy.
[9637592] Epilepsia 39 Suppl 4(-): S42-8 (1998)
1998  
218
Benign epilepsy of childhood with centrotemporal spikes.
[9637591] Epilepsia 39 Suppl 4(-): S32-41 (1998)
1998  
219
Symptomatic occipital lobe epilepsy.
[9637590] Epilepsia 39 Suppl 4(-): S24-31 (1998)
1998  
220
The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine.
[9637589] Epilepsia 39 Suppl 4(-): S9-23 (1998)
1997  
221
1997  
222
The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
[9579887] Epilepsia 38(8): 859-80 (1997)
1997  
223
Origins of the epileptic state.
[9579886] Epilepsia 38(8): 853-8 (1997)
1997  
224
Basic mechanisms of epilepsy: targets for therapeutic intervention.
[9578539] Epilepsia 38 Suppl 9(-): S2-6 (1997)
1997  
225
Neuropsychological evaluation in epilepsy surgery.
[9240237] Epilepsia 38 Suppl 4(-): S18-23 (1997)
1996  
226
Epileptic syndromes: an underutilized concept.
[8917051] Epilepsia 37(11): 1029-34 (1996)
1996  
227
Long-term outcome after epilepsy surgery.
[8814092] Epilepsia 37(9): 807-13 (1996)
1996  
228
Update on the mechanism of action of antiepileptic drugs.
[8941036] Epilepsia 37 Suppl 6(-): S4-11 (1996)
1996  
229
Intractable epilepsy in children.
[8681906] Epilepsia 37 Suppl 3(-): 14-27 (1996)
1995  
230
Neocortical temporal lobe epilepsy: characterizing the syndrome.
[7555977] Epilepsia 36(7): 633-5 (1995)
1995  
231
Clobazam, oxcarbazepine, tiagabine, topiramate, and other new antiepileptic drugs.
[8784219] Epilepsia 36 Suppl 2(-): S105-14 (1995)
1995  
232
Cognitive and behavioral effects of antiepileptic drugs.
[8784214] Epilepsia 36 Suppl 2(-): S46-65 (1995)
1995  
233
Antiepileptic drugs in pediatric practice.
[8784213] Epilepsia 36 Suppl 2(-): S34-45 (1995)
1995  
234
Efficacy and adverse effects of established and new antiepileptic drugs.
[8784211] Epilepsia 36 Suppl 2(-): S13-26 (1995)
1995  
235
Antiepileptic drug mechanisms of action.
[8784210] Epilepsia 36 Suppl 2(-): S2-12 (1995)
2004  
236
Principles of antiepileptic drug treatment of epilepsy.
[15149306] Psychiatry Clin Neurosci 58(3): S3-6 (2004)
2006  
237
Zonisamide - a review of experience and use in partial seizures.
[19412474] Neuropsychiatr Dis Treat 2(3): 269-80 (2006)
2008  
238
Astrocytes in the epileptic brain.
[18439402] Neuron 58(2): 168-78 (2008)
2008  
239
Genetic mechanisms in idiopathic epilepsies.
[18754913] Dev Med Child Neurol 50(9): 648-54 (2008)
2008  
240
Epilepsy surgery: eligibility criteria and presurgical evaluation.
[18472487] Dialogues Clin Neurosci 10(1): 91-103 (2008)
2008  
241
Malformations of cortical development and epilepsy.
[18472484] Dialogues Clin Neurosci 10(1): 47-62 (2008)
2009  
242
Behavioral manifestations of frontal lobe seizures.
[19238120] CNS Spectr 14(2): 66-70 (2009)
2006  
243
Epilepsy: a review of selected clinical syndromes and advances in basic science.
[16437061] J Cereb Blood Flow Metab 26(8): 983-1004 (2006)
2009  
244
Antiepileptic drug monotherapy: the initial approach in epilepsy management.
[19949565] Curr Neuropharmacol 7(2): 77-82 (2009)
2009  
245
Double Trouble? Potential for Hyperexcitability Following Both Channelopathic up- and Downregulation of I(h) in Epilepsy.
[19753094] Front Neurosci 3(1): 25-33 (2009)
2007  
246
Anticonvulsant therapy for status epilepticus.
[17439538] Br J Clin Pharmacol 63(6): 640-7 (2007)
2002  
247
The promise of new antiepileptic drugs.
[11851635] Br J Clin Pharmacol 53(2): 123-31 (2002)
1989  
248
GABAergic mechanisms in the pathogenesis and treatment of epilepsy.
[2667605] Br J Clin Pharmacol 27 Suppl 1(-): 3S-11S (1989)
2006  
249
Post traumatic epilepsy: a review of scientific evidence.
[16850898] Indian J Physiol Pharmacol 50(1): 7-16 (2006)
2006  
250
The clinical effectiveness and cost-effectiveness of newer drugs for children with epilepsy. A systematic review.
[16545206] Health Technol Assess 10(7): iii, ix-118 (2006)
2006  
251
A systematic review of the effectiveness and cost-effectiveness of neuroimaging assessments used to visualise the seizure focus in people with refractory epilepsy being considered for surgery.
[16487454] Health Technol Assess 10(4): 1-250, iii-iv (2006)
2005  
252
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
[15842952] Health Technol Assess 9(15): 1-157, iii-iv (2005)
2003  
253
Genetic basis of autosomal dominant nocturnal frontal lobe epilepsy.
[12773798] J Appl Genet 44(2): 197-207 (2003)
2009  
254
Hemispherotomy: efficacy and analysis of seizure recurrence.
[19795963] J Neurosurg Pediatr 4(4): 323-32 (2009)
2009  
255
Neurosurgical management of intractable rolandic epilepsy in children: role of resection in eloquent cortex. Clinical article.
[19772403] J Neurosurg Pediatr 4(3): 199-216 (2009)
2009  
256
Mesial temporal lobe epilepsy.
[19392600] J Neurosurg 111(6): 1235 (2009)
2009  
257
Morbidity in epilepsy surgery: an experience based on 2449 epilepsy surgery procedures from a single institution.
[19199440] J Neurosurg 110(6): 1111-23 (2009)
2009  
258
Occipital epilepsy: spatial categorization and surgical management.
[19046038] J Neurosurg 110(2): 306-18 (2009)
2008  
259
Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis.
[18826364] J Neurosurg 109(4): 742-5 (2008)
2007  
260
Surgical treatment of epilepsy in Sturge-Weber syndrome in children.
[17233308] J Neurosurg 106(1 Suppl): 20-8 (2007)
2010  
261
Cerebellar stimulation in the management of medically intractable epilepsy: a systematic and critical review.
[20672925] Neurosurg Focus 29(2): E8 (2010)
2010  
262
Disrupting abnormal electrical activity with deep brain stimulation: is epilepsy the next frontier?
[20672924] Neurosurg Focus 29(2): E7 (2010)
2009  
263
Epilepsy and insular Grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases.
[19757989] Neurosurg Focus 27(2): E8 (2009)
2009  
264
Chronic epilepsy associated with temporal tumors: long-term surgical outcome.
[19645562] Neurosurg Focus 27(2): E6 (2009)
2009  
265
2008  
266
Surgical management of hypothalamic hamartomas in patients with gelastic epilepsy.
[18759632] Neurosurg Focus 25(3): E8 (2008)
2008  
267
Surgical treatment of intractable epilepsy associated with focal cortical dysplasia.
[18759630] Neurosurg Focus 25(3): E6 (2008)
2008  
268
Selective amygdalohippocampectomy via the transsylvian approach.
[18759629] Neurosurg Focus 25(3): E5 (2008)
2008  
269
Selective amygdalohippocampectomy: the trans-middle temporal gyrus approach.
[18759628] Neurosurg Focus 25(3): E4 (2008)
2008  
270
Advances in neuroimaging in patients with epilepsy.
[18759627] Neurosurg Focus 25(3): E3 (2008)
2008  
271
Pharmacologically intractable epilepsy in children: diagnosis and preoperative evaluation.
[18759621] Neurosurg Focus 25(3): E2 (2008)
2008  
272
Utility of neuronavigation and neuromonitoring in epilepsy surgery.
[18759618] Neurosurg Focus 25(3): E17 (2008)
2008  
273
The role of magnetoencephalography in epilepsy surgery.
[18759617] Neurosurg Focus 25(3): E16 (2008)
2008  
274
Epilepsy surgery and tuberous sclerosis complex: special considerations.
[18759614] Neurosurg Focus 25(3): E13 (2008)
2008  
275
Deep brain stimulation for medically refractory epilepsy.
[18759612] Neurosurg Focus 25(3): E11 (2008)
2006  
276
Voltage-gated calcium channels and idiopathic generalized epilepsies.
[16816142] Physiol Rev 86(3): 941-66 (2006)
2003  
277
Review of the newer antiepileptic drugs.
[12643343] Am J Manag Care 9(3): 253-76; quiz 277-9 (2003)
2001  
278
The role of new antiepileptic drugs.
[11474769] Am J Manag Care 7(7 Suppl): S209-14 (2001)
1994  
279
The long-term therapeutic management of epilepsy.
[8304660] Ann Intern Med 120(5): 411-22 (1994)
2006  
280
Alternative approaches to conventional antiepileptic drugs in the management of paediatric epilepsy.
[17056869] Arch Dis Child 91(11): 936-41 (2006)
2005  
281
Corticosteroids in the management of the paediatric epilepsies.
[15781928] Arch Dis Child 90(4): 379-84 (2005)
2004  
282
Evidence based guideline for post-seizure management in children presenting acutely to secondary care.
[14977713] Arch Dis Child 89(3): 278-80 (2004)
2003  
283
Mortality in paediatric epilepsy.
[14670777] Arch Dis Child 88(12): 1091-4 (2003)
2000  
284
The treatment of convulsive status epilepticus in children. The Status Epilepticus Working Party, Members of the Status Epilepticus Working Party.
[11040151] Arch Dis Child 83(5): 415-9 (2000)
1999  
285
Update on surgery for epilepsy.
[10490446] Arch Dis Child 81(4): 356-9 (1999)
1999  
286
Typical absence seizures and their treatment.
[10490445] Arch Dis Child 81(4): 351-5 (1999)
1998  
287
Emergency treatment of acute seizures and status epilepticus.
[9771259] Arch Dis Child 79(1): 78-83 (1998)
1998  
288
Status epilepticus: pathophysiology, epidemiology, and outcomes.
[9771258] Arch Dis Child 79(1): 73-7 (1998)
1996  
289
1995  
290
The place of the EEG and imaging in the management of seizures.
[8546519] Arch Dis Child 73(6): 557-62 (1995)
1995  
291
The EEG and neuroimaging in the management of the epilepsies.
[8546518] Arch Dis Child 73(6): 552-7 (1995)
1991  
292
Management of intractable epilepsy.
[1776899] Arch Dis Child 66(12): 1454-6 (1991)
1989  
293
1988  
294
2008  
295
Stereotactic radiosurgery for treatment of epilepsy.
[18268185] Arch Neurol 65(2): 177-83 (2008)
2004  
296
Monotherapy in epilepsy: role of the newer antiepileptic drugs.
[15364680] Arch Neurol 61(9): 1361-5 (2004)
2004  
297
Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane.
[15313843] Arch Neurol 61(8): 1254-9 (2004)
2004  
298
Molecular basis of inherited epilepsy.
[15096393] Arch Neurol 61(4): 473-8 (2004)
2003  
299
Recent advances in the treatment of epilepsy.
[12873848] Arch Neurol 60(7): 929-35 (2003)
2002  
300
2002  
301
Disorders of cortical development and epilepsy.
[11890838] Arch Neurol 59(3): 361-5 (2002)
2002  
302
Refractory status epilepticus in 2001.
[11843688] Arch Neurol 59(2): 188-9 (2002)
2001  
303
The early identification of candidates for epilepsy surgery.
[11594910] Arch Neurol 58(10): 1543-6 (2001)
2001  
304
The requirement for ictal EEG recordings prior to temporal lobe epilepsy surgery.
[11296007] Arch Neurol 58(4): 678-80 (2001)
1999  
305
When to start and stop anticonvulsant therapy in children.
[10488807] Arch Neurol 56(9): 1073-7 (1999)
2008  
306
Benign childhood focal epilepsies: assessment of established and newly recognized syndromes.
[18718967] Brain 131(Pt 9): 2264-86 (2008)
2007  
307
The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy.
[17947336] Brain 130(Pt 12): 3135-48 (2007)
2007  
308
EEG-fMRI in the preoperative work-up for epilepsy surgery.
[17586868] Brain 130(Pt 9): 2343-53 (2007)
2007  
309
Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects.
[17124190] Brain 130(Pt 2): 334-45 (2007)
2007  
310
Seizure prediction: the long and winding road.
[17008335] Brain 130(Pt 2): 314-33 (2007)
2006  
311
Molecular and cellular mechanisms of pharmacoresistance in epilepsy.
[16317026] Brain 129(Pt 1): 18-35 (2006)
2005  
312
Quantitative post-mortem study of the hippocampus in chronic epilepsy: seizures do not inevitably cause neuronal loss.
[15758032] Brain 128(Pt 6): 1344-57 (2005)
2005  
313
Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis.
[15758038] Brain 128(Pt 5): 1188-98 (2005)
2004  
314
Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases.
[15090473] Brain 127(Pt 6): 1343-52 (2004)
2003  
315
Occipital epilepsies: identification of specific and newly recognized syndromes.
[12615636] Brain 126(Pt 4): 753-69 (2003)
2003  
316
Severe infantile epilepsies: molecular genetics challenge clinical classification.
[12566273] Brain 126(Pt 3): 513-4 (2003)
2002  
317
Disease modification in partial epilepsy.
[12183340] Brain 125(Pt 9): 1937-50 (2002)
2001  
318
Ictal bradycardia in partial epileptic seizures: Autonomic investigation in three cases and literature review.
[11701591] Brain 124(Pt 12): 2361-71 (2001)
2001  
319
Presurgical evaluation of epilepsy.
[11522572] Brain 124(Pt 9): 1683-700 (2001)
2000  
320
Surgery for malformations of cortical development causing epilepsy.
[10825348] Brain 123 ( Pt 6)(-): 1075-91 (2000)
1999  
321
1999  
322
Nocturnal frontal lobe epilepsy. A clinical and polygraphic overview of 100 consecutive cases.
[10356056] Brain 122 ( Pt 6)(-): 1017-31 (1999)
1999  
323
Hippocampal sclerosis and temporal lobe epilepsy: cause or consequence?
[10356054] Brain 122 ( Pt 6)(-): 1007-8 (1999)
1997  
324
1973  
325
Recent progress in epilepsy. Diagnostic procedures and treatment.
[4581416] Calif Med 119(1): 19-48 (1973)
1969  
326
Clinical aspects of temporal lobe epilepsy--a review.
[4894817] Calif Med 110(4): 325-9 (1969)
1983  
327
Drug treatment of epilepsy: a review.
[6336967] Can Med Assoc J 128(3): 261-70 (1983)
2004  
328
The management of status epilepticus.
[15302747] Chest 126(2): 582-91 (2004)
2008  
329
2008  
330
Neurogenesis and epilepsy in the developing brain.
[18522600] Epilepsia 49 Suppl 5(-): 50-4 (2008)
2007  
331
Relevance of seizure-induced neurogenesis in animal models of epilepsy to the etiology of temporal lobe epilepsy.
[17571351] Epilepsia 48 Suppl 2(-): 33-41 (2007)
2006  
332
Posttraumatic epilepsy: a major problem in desperate need of major advances.
[16477313] Epilepsy Curr 6(1): 1-5 (2006)
2005  
333
Imaging of serotonin mechanisms in epilepsy.
[16372050] Epilepsy Curr 5(6): 201-6 (2005)
2005  
334
Sacred disease secrets revealed: the genetics of human epilepsy.
[16049035] Hum Mol Genet 14(17): 2491-500 (2005)
2003  
335
2002  
336
Surgical treatment of temporal lobe epilepsy.
[12397134] J Neurol Neurosurg Psychiatry 73(5): 470 (2002)
2001  
337
2001  
338
2000  
339
2000  
340
1994  
341
1993  
342
1993  
343
Benign childhood partial epilepsies: benign childhood seizure susceptibility syndromes.
[8429319] J Neurol Neurosurg Psychiatry 56(1): 2-5 (1993)
1983  
344
Prolactin and gonadotrophin changes following generalised and partial seizures.
[6405014] J Neurol Neurosurg Psychiatry 46(4): 331-5 (1983)
1994  
345
Cellular and molecular basis of epilepsy.
[8207463] J Neurosci 14(6): 3413-25 (1994)
2004  
346
The new antiepileptic drugs: clinical applications.
[14762041] JAMA 291(5): 615-20 (2004)
2004  
347
The new antiepileptic drugs: scientific review.
[14762040] JAMA 291(5): 605-14 (2004)
2004  
348
Seizure prophylaxis in patients with brain tumors: a meta-analysis.
[15595331] Mayo Clin Proc 79(12): 1489-94 (2004)
2003  
349
Neuropsychiatric and memory issues in epilepsy.
[12934792] Mayo Clin Proc 78(6): 781-7 (2003)
2003  
350
New management strategies in the treatment of status epilepticus.
[12683704] Mayo Clin Proc 78(4): 508-18 (2003)
2003  
351
Therapeutics in pediatric epilepsy, Part 2: Epilepsy surgery and vagus nerve stimulation.
[12630591] Mayo Clin Proc 78(3): 371-8 (2003)
2003  
352
Therapeutics in pediatric epilepsy, Part 1: The new antiepileptic drugs and the ketogenic diet.
[12630590] Mayo Clin Proc 78(3): 359-70 (2003)
2003  
353
Neurostimulation therapy for epilepsy: current modalities and future directions.
[12583536] Mayo Clin Proc 78(2): 238-48 (2003)
2002  
354
Antiepileptic drug withdrawal: literature review.
[12479528] Mayo Clin Proc 77(12): 1378-88 (2002)
2002  
355
Antiepileptic drug therapy for adults: when to initiate and how to choose.
[12479527] Mayo Clin Proc 77(12): 1367-75 (2002)
2002  
356
Role of neuroimaging in the management of seizure disorders.
[12440562] Mayo Clin Proc 77(11): 1251-64 (2002)
2002  
357
Clinical indications and diagnostic yield of video-electroencephalographic monitoring in patients with seizures and spells.
[12374255] Mayo Clin Proc 77(10): 1111-20 (2002)
2002  
358
Role and limitations of routine and ambulatory scalp electroencephalography in diagnosing and managing seizures.
[12233935] Mayo Clin Proc 77(9): 991-8 (2002)
2002  
359
Characteristics of the epilepsies.
[12233934] Mayo Clin Proc 77(9): 981-90 (2002)
2003  
360
The role of emergent neuroimaging in children with new-onset afebrile seizures.
[12509546] Pediatrics 111(1): 1-5 (2003)
2006  
361
Generalised convulsive status epilepticus: an overview.
[17099091] Postgrad Med J 82(973): 723-32 (2006)
2006  
362
Post-stroke seizure and post-stroke epilepsy.
[16954451] Postgrad Med J 82(971): 568-72 (2006)
2005  
363
The approach to patients with "non-epileptic seizures".
[16085740] Postgrad Med J 81(958): 498-504 (2005)
2004  
364
New drugs for the treatment of epilepsy: a practical approach.
[15466993] Postgrad Med J 80(948): 581-7 (2004)
2001  
365
Seizure disorders: Part 2. Treatment.
[11527850] West J Med 175(3): 184-8 (2001)
1991  
366
Status epilepticus. Clinical features, pathophysiology, and treatment.
[1812633] West J Med 155(6): 626-31 (1991)
2001  
367
Imaging in epilepsy: a paediatric perspective.
[11509392] Br J Radiol 74(883): 575-89 (2001)
2008  
368
Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy.
[18716125] AJR Am J Roentgenol 191(3): 890-5 (2008)
1997  
369
A systematic approach for interpreting MR images of the seizure patient.
[9207533] AJR Am J Roentgenol 169(1): 241-7 (1997)
1992  
370
2004  
371
The relative localizing value of interictal and immediate postictal SPECT in seizures of temporal lobe origin.
[15585476] J Nucl Med 45(12): 2021-5 (2004)
1998  
372
SPECT brain imaging in epilepsy: a meta-analysis.
[9476937] J Nucl Med 39(2): 285-93 (1998)
1991  
373
1990  
374
Complex partial epilepsy: the role of neuroimaging in localizing a seizure focus for surgical intervention.
[2230998] J Nucl Med 31(11): 1839-43 (1990)
2008  
375
Neuroimaging in pediatric epilepsy: a multimodality approach.
[18635630] Radiographics 28(4): 1079-95 (2008)
2003  
376
Diagnosis and management of epilepsy.
[12591787] CMAJ 168(4): 441-8 (2003)
2002  
377
Magnetoencephalographically directed review of high-spatial-resolution surface-coil MR images improves lesion detection in patients with extratemporal epilepsy.
[12461274] Radiology 225(3): 880-7 (2002)
1993  
378
Epilepsy: surgery and imaging.
[8234683] Radiology 189(3): 635-46 (1993)
2009  
379
[18F] fluorodeoxyglucose-positron-emission tomography and MR imaging coregistration for presurgical evaluation of medically refractory epilepsy.
[19628624] AJNR Am J Neuroradiol 30(10): 1811-6 (2009)
2005  
380
Diffusion-weighted imaging of acute excitotoxic brain injury.
[15709116] AJNR Am J Neuroradiol 26(2): 216-28 (2005)
2001  
381
Pictorial review of glutamate excitotoxicity: fundamental concepts for neuroimaging.
[11733308] AJNR Am J Neuroradiol 22(10): 1813-24 (2001)
1998  
382
MR spectroscopy of temporal lobe epilepsy: good news and bad news.
[9432179] AJNR Am J Neuroradiol 19(1): 189 (1998)
1997  
383
2009  
384
The mechanisms of medically refractory temporal lobe epilepsy.
[19960958] Acta Neurol Taiwan 18(3): 155-60 (2009)
2010  
385
Mesial temporal lobe epilepsy: How do we improve surgical outcome?
[20976764] Ann Neurol 68(4): 424-34 (2010)
2007  
386
Mesial temporal sclerosis in children.
[18094851] Arq Neuropsiquiatr 65(4A): 947-50 (2007)
2007  
387
2009  
388
Could sudden cardiac death in epilepsy be related to the occurrence of thalamic dysfunction or anatomic change?
[19330235] Arq Neuropsiquiatr 67(1): 139-43 (2009)
2007  
389
Natural approaches to epilepsy.
[17397265] Altern Med Rev 12(1): 9-24 (2007)
2006  
390
Teratogenicity of antiepileptic drugs.
[16990299] BMJ 333(7569): 615-6 (2006)
2010  
391
Biofeedback in the treatment of epilepsy.
[20622079] Cleve Clin J Med 77 Suppl 3(-): S60-7 (2010)
2010  
392
Pharmacoresistant epilepsy: from pathogenesis to current and emerging therapies.
[20601619] Cleve Clin J Med 77(7): 457-67 (2010)
2004  
393
Bone disease associated with antiepileptic drugs.
[15379299] Cleve Clin J Med 71 Suppl 2(-): S42-8 (2004)
2006  
394
Refractory status epilepticus.
[17114841] Neurol India 54(4): 354-8 (2006)
2011  
395
Managing epilepsy in pregnancy.
[21339661] Neurol India 59(1): 59-65 (2011)
2010  
396
Structural and functional neuroimaging in intractable epilepsy.
[20644262] Neurol India 58(3): 361-70 (2010)
2011  
397
Neonatal seizures: diagnosis and management.
[21342614] Zhongguo Dang Dai Er Ke Za Zhi 13(2): 81-100 (2011)
2010  
398
Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects.
[20351042] J Physiol 588(Pt 11): 1841-8 (2010)
2010  
399
Mutations in GABAA receptor subunits associated with genetic epilepsies.
[20308251] J Physiol 588(Pt 11): 1861-9 (2010)
2010  
400
2010  
401
Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.
[20156848] J Physiol 588(Pt 11): 1905-13 (2010)
2008  
402
Nervous system KV7 disorders: breakdown of a subthreshold brake.
[18238816] J Physiol 586(7): 1791-801 (2008)
2010  
403
Neonatal vitamin-responsive epileptic encephalopathies.
[20184790] Chang Gung Med J 33(1): 1-12 (2010)
2007  
404
Vitamin B6 related epilepsy during childhood.
[18062169] Chang Gung Med J 30(5): 396-401 (2007)
2008  
405
Long-term anterior thalamus stimulation for intractable epilepsy.
[18782952] Chang Gung Med J 31(3): 287-96 (2008)
2010  
406
The treatment of women with epilepsy.
[21124696] Dtsch Arztebl Int 107(45): 787-93 (2010)
2011  
407
Melatonin in experimental seizures and epilepsy.
[21441606] Pharmacol Rep 63(1): 1-11 (2011)
2010  
408
Immunological aspects of epilepsy.
[20885000] Pharmacol Rep 62(4): 592-607 (2010)
2008  
409
2008  
410
A 24-year-old woman with intractable seizures: review of surgery for epilepsy.
[18984876] JAMA 300(21): 2527-38 (2008)
2011  
411
2007  
412
EEG diagnosis of nonconvulsive status epilepticus: generalized periodic patterns--status or not?
[18052759] Expert Rev Neurother 7(12): 1643-4 (2007)
2008  
413
2008  
414
Somatostatin: an endogenous antiepileptic.
[18221832] Mol Cell Endocrinol 286(1-2): 96-103 (2008)
2003  
415
Pyridoxine-dependent seizures: a review.
[12881619] Indian Pediatr 40(7): 633-8 (2003)
2007  
416
Role of surgery in pediatric epilepsy.
[17468521] Indian Pediatr 44(4): 263-73 (2007)
2009  
417
Ketogenic diet in the management of childhood epilepsy.
[19717858] Indian Pediatr 46(8): 663-4 (2009)
2009  
418
Guidelines for diagnosis and management of childhood epilepsy.
[19717860] Indian Pediatr 46(8): 681-98 (2009)
2010  
419
Coexistent pathology in chronic epilepsy patients with neoplasms.
[20495542] Mod Pathol 23(8): 1097-103 (2010)
2010  
420
Review of topiramate for the treatment of epilepsy in elderly patients.
[20458347] Clin Interv Aging 5(-): 89-99 (2010)
2005  
421
Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy.
[15737406] Pharmacol Ther 105(3): 229-66 (2005)
2008  
422
Which should be the first-line drug for newly diagnosed epilepsy? Commentary on the SANAD study.
[18405167] Pol Arch Med Wewn 118(1-2): 11-3 (2008)
2009  
423
Embryonic stem cell-derived neural precursor grafts for treatment of temporal lobe epilepsy.
[19332319] Neurotherapeutics 6(2): 263-77 (2009)
2009  
424
Engineered adenosine-releasing cells for epilepsy therapy: human mesenchymal stem cells and human embryonic stem cells.
[19332320] Neurotherapeutics 6(2): 278-83 (2009)
2009  
425
Alteration of epileptogenesis genes.
[19332325] Neurotherapeutics 6(2): 312-8 (2009)
2009  
426
Nanotechnology for delivery of drugs to the brain for epilepsy.
[19332327] Neurotherapeutics 6(2): 323-36 (2009)
2009  
427
Convection-enhanced delivery in the treatment of epilepsy.
[19332329] Neurotherapeutics 6(2): 344-51 (2009)
2009  
428
Neurosteroid replacement therapy for catamenial epilepsy.
[19332335] Neurotherapeutics 6(2): 392-401 (2009)
2010  
429
Mutations affecting GABAergic signaling in seizures and epilepsy.
[20352446] Pflugers Arch 460(2): 505-23 (2010)
2004  
430
Gratification disorder ("infantile masturbation"): a review.
[14977696] Arch Dis Child 89(3): 225-6 (2004)
2007  
431
Outcome of convulsive status epilepticus: a review.
[17954477] Arch Dis Child 92(11): 948-51 (2007)
2005  
432
Anoxic-epileptic seizures: observational study of epileptic seizures induced by syncopes.
[16159903] Arch Dis Child 90(12): 1283-7 (2005)
2009  
433
Insular lesionectomy for refractory epilepsy: management and outcome.
[19297505] Brain 132(Pt 4): 1048-56 (2009)
2005  
434
Cortical triggers in generalized reflex seizures and epilepsies.
[15728654] Brain 128(Pt 4): 700-10 (2005)
2006  
435
Best evidence topic reports. Lorazepam or diazepam in paediatric status epilepticus.
[16714516] Emerg Med J 23(6): 472-3 (2006)
2006  
436
Morbidity associated with the use of intracranial electrodes for epilepsy surgery.
[16736735] Can J Neurol Sci 33(2): 223-7 (2006)
2003  
437
Natural history of absence epilepsy in children.
[12945939] Can J Neurol Sci 30(3): 184-8 (2003)
2003  
438
Epileptogenesis, ictogenesis and the design of future antiepileptic drugs.
[12619776] Can J Neurol Sci 30(1): 4-7 (2003)
2005  
439
The epileptic encephalopathies of infancy and childhood.
[16408569] Can J Neurol Sci 32(4): 409-18 (2005)
2005  
440
Visual-sensitive epilepsies: classification and review.
[16225169] Can J Neurol Sci 32(3): 298-305 (2005)
2011  
441
Update on rufinamide in childhood epilepsy.
[21792306] Neuropsychiatr Dis Treat 7(-): 399-407 (2011)
2010  
442
Clinical profile of vigabatrin as monotherapy for treatment of infantile spasms.
[21127692] Neuropsychiatr Dis Treat 6(-): 731-40 (2010)
2007  
443
2009  
444
Emerging concepts in the pathogenesis of epilepsy and epileptogenesis.
[19364928] Arch Neurol 66(4): 443-7 (2009)
2004  
445
An approach to the evaluation of a patient for seizures and epilepsy.
[15101468] WMJ 103(1): 49-55 (2004)
2004  
446
Updates on the treatment of epilepsy in women.
[14744836] Arch Intern Med 164(2): 137-45 (2004)
2011  
447
Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting.
[21694817] Ther Adv Neurol Disord 4(3): 169-81 (2011)
2008  
448
Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited.
[21180561] Ther Adv Neurol Disord 1(1): 13-24 (2008)
2008  
449
Recent and future advances in the treatment of status epilepticus.
[21180563] Ther Adv Neurol Disord 1(1): 33-42 (2008)
2009  
450
New treatment options in status epilepticus: a critical review on intravenous levetiracetam.
[21180643] Ther Adv Neurol Disord 2(2): 79-91 (2009)
2007  
451
Cell and gene therapies for refractory epilepsy.
[18615179] Curr Neuropharmacol 5(2): 115-25 (2007)
2009  
452
Monitoring antiepileptic drugs: a level-headed approach.
[19949569] Curr Neuropharmacol 7(2): 115-9 (2009)
2011  
453
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin.
[21941443] Ther Clin Risk Manag 7(-): 367-75 (2011)
2010  
454
Epilepsy surgery: recommendations for India.
[20814490] Ann Indian Acad Neurol 13(2): 87-93 (2010)
2010  
455
Guidelines for epilepsy management in India classification of seizures and epilepsy syndromes.
[21264131] Ann Indian Acad Neurol 13(4): 247-9 (2010)
2009  
456
Oxcarbazepine for refractory epilepsy: systematic review of the literature.
[19820875] Sao Paulo Med J 127(3): 150-9 (2009)
2003  
457
Management of treatment-resistant epilepsy.
[12820535] Evid Rep Technol Assess (Summ) -(77): 1-8 (2003)
2008  
458
Nonepileptic motor phenomena in the neonate.
[19436521] Paediatr Child Health 13(8): 680-4 (2008)
2009  
459
Neonatal seizures: an update on mechanisms and management.
[19944840] Clin Perinatol 36(4): 881-900, vii (2009)
2010  
460
Treatment strategies in the postictal state.
[20719574] Epilepsy Behav 19(2): 188-90 (2010)
2010  
461
The postictal state: effects of age and underlying brain dysfunction.
[20724220] Epilepsy Behav 19(2): 118-20 (2010)
2010  
462
Toward rational design of electrical stimulation strategies for epilepsy control.
[19926525] Epilepsy Behav 17(1): 6-22 (2010)
2010  
463
Urgent continuous EEG (cEEG) monitoring leads to changes in treatment in half of cases.
[20697500] Epilepsy Curr 10(4): 82-5 (2010)
2011  
464
Does acquired epileptogenesis in the immature brain require neuronal death.
[21461261] Epilepsy Curr 11(1): 21-6 (2011)
2010  
465
Less common etiologies of status epilepticus.
[20231917] Epilepsy Curr 10(2): 31-3 (2010)
2007  
466
2007  
467
Persistent sodium current and its role in epilepsy.
[17304346] Epilepsy Curr 7(1): 15-22 (2007)
2009  
468
The descriptive epidemiology of epilepsy-a review.
[19369037] Epilepsy Res 85(1): 31-45 (2009)
2009  
469
The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.
[19406620] Epilepsy Res 85(1): 1-30 (2009)
2009  
470
Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.
[19428218] Epilepsy Res 85(2-3): 131-41 (2009)
2008  
471
Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy.
[18226499] Epilepsy Res 78(2-3): 102-16 (2008)
2002  
472
ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability.
[12040892] Int Rev Neurobiol 49(-): 185-97 (2002)
2008  
473
Choosing the correct antiepileptic drugs: from animal studies to the clinic.
[18279749] Pediatr Neurol 38(3): 151-62 (2008)
2009  
474
Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management.
[19739692] CNS Drugs 23(10): 805-15 (2009)
2010  
475
The relationship of interictal epileptiform discharges to clinical epilepsy severity: a study of routine electroencephalograms and review of the literature.
[20234317] J Clin Neurophysiol 27(2): 87-92 (2010)
2011  
476
2002  
477
Rationale for treating epilepsy in children.
[12424080] Epileptic Disord 4 Suppl 2(-): S9-21 (2002)
2002  
478
Epilepsy in elderly people: management issues.
[12424082] Epileptic Disord 4 Suppl 2(-): S33-9 (2002)
2002  
479
Recent developments in treatment of status epilepticus: a review.
[12424083] Epileptic Disord 4 Suppl 2(-): S41-51 (2002)
2002  
480
2004  
481
The mortality of epilepsy revisited.
[15075062] Epileptic Disord 6(1): 3-13 (2004)
2004  
482
2004  
483
The choice of antiepileptic drugs in newly diagnosed epilepsy: a national French survey.
[15634622] Epileptic Disord 6(4): 255-65 (2004)
2003  
484
Alternative surgical procedures to help drug-resistant epilepsy - a review.
[12875950] Epileptic Disord 5(2): 63-75 (2003)
2003  
485
MR imaging of epilepsy: state of the art at 1.5 T and potential of 3 T.
[12773291] Epileptic Disord 5(1): 3-20 (2003)
2003  
486
Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine.
[12773297] Epileptic Disord 5(1): 51-6 (2003)
2007  
487
Treatment of pediatric epilepsy: European expert opinion, 2007.
[18077226] Epileptic Disord 9(4): 353-412 (2007)
2007  
488
Non-invasive alternatives to the Wada test in the presurgical evaluation of language and memory functions in epilepsy patients.
[17525019] Epileptic Disord 9(2): 111-26 (2007)
2005  
489
A semiological classification of status epilepticus.
[15741134] Epileptic Disord 7(1): 5-12 (2005)
2005  
490
Chromosomal disorders associated with epilepsy.
[16162426] Epileptic Disord 7(3): 181-92 (2005)
2005  
491
Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports.
[16162436] Epileptic Disord 7(3): 253-96 (2005)
2008  
492
Epilepsia partialis continua: semiology and differential diagnoses.
[18367424] Epileptic Disord 10(1): 3-7 (2008)
2005  
493
Making sense of non-epileptic seizures.
[15929914] Epileptic Disord 7(2): 123-30 (2005)
2005  
494
Epilepsy in inborn errors of metabolism.
[15929908] Epileptic Disord 7(2): 67-81 (2005)
2008  
495
The adenosine kinase hypothesis of epileptogenesis.
[18249058] Prog Neurobiol 84(3): 249-62 (2008)
2010  
496
Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis.
[20188170] Neurobiol Dis 39(1): 53-60 (2010)
2010  
497
Is epilepsy a preventable disorder? New evidence from animal models.
[20479472] Neuroscientist 16(3): 253-75 (2010)
2010  
498
Posttraumatic epilepsy: the roles of synaptic plasticity.
[19359668] Neuroscientist 16(1): 19-27 (2010)
2008  
499
Potassium dynamics in the epileptic cortex: new insights on an old topic.
[18997121] Neuroscientist 14(5): 422-33 (2008)
2008  
500
Epilepsy, E/I Balance and GABA(A) Receptor Plasticity.
[18946538] Front Mol Neurosci 1(-): 5 (2008)
2010  
501
Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy.
[20146928] Neuropharmacology 58(6): 855-64 (2010)
2005  
502
Neuroimaging of epilepsy: therapeutic implications.
[15897958] NeuroRx 2(2): 384-93 (2005)
2007  
503
2007  
504
The state of the art in the genetic analysis of the epilepsies.
[17618539] Curr Neurol Neurosci Rep 7(4): 320-8 (2007)
2004  
505
2011  
506
Cell signaling underlying epileptic behavior.
[21852968] Front Behav Neurosci 5(-): 45 (2011)
2009  
507
Meta-analysis of kindling-induced gene expression changes in the rat hippocampus.
[20582280] Front Neurosci 3(-): 53 (2009)
2011  
508
Concepts of connectivity and human epileptic activity.
[21472027] Front Syst Neurosci 5(-): 12 (2011)
2009  
509
Epileptogenesis in the immature brain: emerging mechanisms.
[19578345] Nat Rev Neurol 5(7): 380-91 (2009)
2009  
510
Identification of pharmacoresistant epilepsy.
[19853220] Neurol Clin 27(4): 1003-13 (2009)
2009  
511
Hormonal aspects of epilepsy.
[19853217] Neurol Clin 27(4): 941-65 (2009)
2009  
512
The emerging architecture of neuropsychological impairment in epilepsy.
[19853214] Neurol Clin 27(4): 881-907 (2009)
2003  
513
Postoperative seizures: epidemiology, pathology, and prophylaxis.
[14723265] Neurol Med Chir (Tokyo) 43(12): 589-600; discussion 600 (2003)
2007  
514
Stroke-related seizures and epilepsy.
[17530577] Neurol Neurochir Pol 41(2): 144-9 (2007)
2010  
515
Inhibitory RNA in epilepsy: research tools and therapeutic perspectives.
[20633035] Epilepsia 51(9): 1659-68 (2010)
2010  
516
Interneurons, GABAA currents, and subunit composition of the GABAA receptor in type I and type II cortical dysplasia.
[20618425] Epilepsia 51 Suppl 3(-): 166-70 (2010)
2010  
517
Abnormal pyramidal cell morphology and HCN channel expression in cortical dysplasia.
[20618401] Epilepsia 51 Suppl 3(-): 52-5 (2010)
2010  
518
Modeling new therapies for infantile spasms.
[20618396] Epilepsia 51 Suppl 3(-): 27-33 (2010)
2010  
519
Therapeutic approaches to epileptogenesis--hope on the horizon.
[20618393] Epilepsia 51 Suppl 3(-): 2-17 (2010)
2010  
520
The natural history of epilepsy in tuberous sclerosis complex.
[20041940] Epilepsia 51(7): 1236-41 (2010)
2008  
521
Energy metabolism as part of the anticonvulsant mechanism of the ketogenic diet.
[19049599] Epilepsia 49 Suppl 8(-): 91-3 (2008)
2010  
522
Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies.
[19817806] Epilepsia 51(1): 27-36 (2010)
2009  
523
Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis.
[19187292] Epilepsia 50 Suppl 2(): 30-40 (2009)
2009  
524
2010  
525
Seizure semiology: an overview of the 'inverse problem'.
[19923838] Eur Neurol 63(1): 3-10 (2010)
2010  
526
Transcranial magnetic stimulation for drug-resistant epilepsies: rationale and clinical experience.
[20150738] Eur Neurol 63(4): 205-10 (2010)
2010  
527
Lessons from the laboratory: the pathophysiology, and consequences of status epilepticus.
[20727481] Semin Pediatr Neurol 17(3): 136-43 (2010)
2007  
528
Cognitive and magnetic resonance volumetric abnormalities in new-onset pediatric epilepsy.
[18070673] Semin Pediatr Neurol 14(4): 173-80 (2007)
2010  
529
Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy.
[21173849] F1000 Med Rep 2(-): 51 (2010)
2010  
530
The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1.
[20814824] J Inherit Metab Dis 33(5): 571-81 (2010)
2011  
531
The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy.
[21941613] Int J Physiol Pathophysiol Pharmacol 3(3): 223-35 (2011)
2011  
532
Frontier of epilepsy research - mTOR signaling pathway.
[21467839] Exp Mol Med 43(5): 231-74 (2011)
2010  
533
"Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings.
[21629447] Curr Neuropharmacol 8(4): 409-21 (2010)
2010  
534
2010  
535
Incidence and clinical decision making for the Wada test over one decade: 1997-2007.
[20940113] Epileptic Disord 12(4): 249-54 (2010)
2011  
536
The role of inflammation in epilepsy.
[21135885] Nat Rev Neurol 7(1): 31-40 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Epilepsy (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Epilepsy (BASKET).php on line 92